Drugs / CBT005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07668466 | Jul 2026 → Aug 2028 expected | lumbar disk degenerative disorder | Cartago Biotech Pty Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBT005 | “Researchers will test a medicine called CBT005, which contains a healing protein” NCT07668466 ↗ |
| Modality | Protein / enzyme biologic | “which contains a healing protein” NCT07668466 ↗ |
| Route | Other | “by injecting it into the spinal discs” NCT07668466 ↗ |